| Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis Z Zhu, S Du, Y Du, J Ren, G Ying, Z Yan Journal of neurochemistry 144 (1), 93-104, 2018 | 149 | 2018 |
| Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells Y Gao, X Ni, H Guo, Z Su, Y Ba, Z Tong, Z Guo, X Yao, X Chen, J Yin, ... Genome research 27 (8), 1312-1322, 2017 | 106 | 2017 |
| Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review N Li, HY Huang, DW Wu, ZM Yang, J Wang, JS Wang, SH Wang, H Fang, ... The Lancet Oncology 20 (11), e619-e626, 2019 | 90 | 2019 |
| A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors Z Zhu, Z Qian, Z Yan, C Zhao, H Wang, G Ying International journal of nanomedicine, 129-136, 2013 | 90 | 2013 |
| Promoter hypermethylation correlates with the Hsulf‐1 silencing in human breast and gastric cancer Z Chen, JQ Fan, J Li, QS Li, Z Yan, XK Jia, WD Liu, LJ Wei, FZ Zhang, ... International journal of cancer 124 (3), 739-744, 2009 | 75 | 2009 |
| Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies H Bao, Q Zhang, H Xu, Z Yan International journal of nanomedicine, 929-940, 2016 | 62 | 2016 |
| Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial H Bao, Y Lv, D Wang, J Xue, Z Yan European Journal of Clinical Microbiology & Infectious Diseases 36, 459-466, 2017 | 54 | 2017 |
| Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors Z Yan, Z Zhu, Z Qian, G Hu, H Wang, W Liu, G Cheng Acta Pharmacologica Sinica 33 (6), 852-858, 2012 | 41 | 2012 |
| BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling H Bao, Q Zhang, Z Zhu, H Xu, F Ding, M Wang, S Du, Y Du, Z Yan Scientific reports 7 (1), 9153, 2017 | 40 | 2017 |
| Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O6-methylguanine-DNA methyltransferase (MGMT) expression Z Zhu, S Du, F Ding, S Guo, G Ying, Z Yan American journal of translational research 8 (7), 3299, 2016 | 40 | 2016 |
| A multicentre randomised trial comparing weekly paclitaxel+ S-1 with weekly paclitaxel+ 5-fluorouracil for patients with advanced gastric cancer D Huang, Y Ba, J Xiong, N Xu, Z Yan, Z Zhuang, Z Yu, H Wan, Y Zhang, ... European Journal of Cancer 49 (14), 2995-3002, 2013 | 36 | 2013 |
| Differentiating malignant colorectal tumor patients from benign colorectal tumor patients by assaying morning urinary arylsulfatase activity R Niu, H Jing, Z Chen, J Xu, J Dai, Z Yan Asia‐Pacific Journal of Clinical Oncology 8 (4), 362-367, 2012 | 25 | 2012 |
| Silk fibroin peptide suppresses proliferation and induces apoptosis and cell cycle arrest in human lung cancer cells M Wang, Y Du, H Huang, Z Zhu, S Du, S Chen, H Zhao, Z Yan Acta Pharmacologica Sinica 40 (4), 522-529, 2019 | 21 | 2019 |
| Synthesis, characterization, and evaluation of a novel inhibitor of WNT/β-catenin signaling pathway Z Yan, Z Zhu, J Wang, J Sun, Y Chen, G Yang, W Chen, Y Deng Molecular cancer 12, 1-10, 2013 | 20 | 2013 |
| 高聚生在肿瘤临床治疗中的应用 阎昭， 陈军， 赵文华， 郭巍， 综述， 刘昌孝， 审稿 中国肿瘤临床 35 (016), 953-959, 2008 | 19 | 2008 |
| Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV P Xing, J Zhang, Z Yan, G Zhao, X Li, G Wang, Y Yang, J Zhao, R Xing, ... Oncotarget 8 (22), 36716, 2017 | 18 | 2017 |
| Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways Z Zhu, T Jiang, H Suo, S Xu, C Zhang, G Ying, Z Yan Frontiers in Pharmacology 12, 712181, 2021 | 15 | 2021 |
| The impact of camptothecin-encapsulated poly(lactic-co-glycolic acid) nanoparticles on the activity of cytochrome P450 in vitro H Bao, Q Zhang, Z Yan International journal of nanomedicine, 383-391, 2019 | 12 | 2019 |
| BHX inhibits the Wnt signaling pathway by suppressing β-catenin transcription in the nucleus F Ding, M Wang, Y Du, S Du, Z Zhu, Z Yan Scientific Reports 6 (1), 38331, 2016 | 11 | 2016 |
| Apoptosis induction in K562 human myelogenous leukaemia cells is connected to the modulation of Wnt/β‐catenin signalling by BHX, a novel pyrazoline derivative H Bao, Q Zhang, Y Du, C Zhang, H Xu, Z Zhu, Z Yan Cell Proliferation 51 (3), e12433, 2018 | 10 | 2018 |
